Current market catalysts

Oppenheimer Reiterates Outperform on Salesforce, Raises Price Target to $275

Oppenheimer analyst Brian Schwartz reiterates Salesforce (NYSE:CRM) with a Outperform and raises the price target from $250 to $275.

$1000 Invested In MACOM Technology Solns 10 Years Ago Would Be Worth This Much Today

MACOM Technology Solns (NASDAQ:MTSI) has outperformed the market over the past 10 years by 7.57% on an annualized basis producing an average annual return of 21.05%. Currently, MACOM Technology Solns has a market

Ohmyhome shares are trading lower after the company announced a 1-for-50 reverse stock split.

Oppenheimer Maintains Outperform on Ridgepost Capital, Lowers Price Target to $15

Oppenheimer analyst Chris Kotowski maintains Ridgepost Capital (NYSE:RPC) with a Outperform and lowers the price target from $16 to $15.

RBC Capital Maintains Outperform on Veeva Systems, Raises Price Target to $325

RBC Capital analyst Rishi Jaluria maintains Veeva Systems (NYSE:VEEV) with a Outperform and raises the price target from $275 to $325.

Citrini Research Bets on a ‘Treasury Twist’: Why the 30-Year Bond Could Rally

Citrini Research predicts a Treasury twist in the market, with banks replacing the Fed as buyers of government debt, leading to a potential short squeeze on 30-year bonds.

RBC Capital Maintains Outperform on JM Smucker, Raises Price Target to $150

RBC Capital analyst Nik Modi maintains JM Smucker (NYSE:SJM) with a Outperform and raises the price target from $135 to $150.

Oppenheimer Maintains Outperform on Revolution Medicines, Raises Price Target to $260

Oppenheimer analyst Jay Olson maintains Revolution Medicines (NASDAQ:RVMD) with a Outperform and raises the price target from $230 to $260.

Laser Photonics shares are trading higher after the company announced continued advancement of its Laser Shield Anti-Drone system following a direct engagement with U.S. Special Operations Command.

RBC Capital Maintains Outperform on Targa Resources, Raises Price Target to $338

RBC Capital analyst Elvira Scotto maintains Targa Resources (NYSE:TRGP) with a Outperform and raises the price target from $312 to $338.

RBC Capital Maintains Sector Perform on Salesforce, Raises Price Target to $250

RBC Capital analyst Rishi Jaluria maintains Salesforce (NYSE:CRM) with a Sector Perform and raises the price target from $210 to $250.

RBC Capital Maintains Outperform on Okta, Raises Price Target to $195

RBC Capital analyst Matthew Hedberg maintains Okta (NASDAQ:OKTA) with a Outperform and raises the price target from $166 to $195.

8-K filing — URBAN OUTFITTERS INC (URBN)

Filed: 2026-08-27 AccNo: 0001193125-26-369924 Size: 1 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

UBS Maintains Neutral on Progressive, Raises Price Target to $234

UBS analyst Brian Meredith maintains Progressive (NYSE:PGR) with a Neutral and raises the price target from $225 to $234.

RBC Capital Maintains Outperform on Nutanix, Raises Price Target to $90

RBC Capital analyst Matthew Hedberg maintains Nutanix (NASDAQ:NTNX) with a Outperform and raises the price target from $84 to $90.

Valion Bio shares are trading lower after the company announced a 1-for-25 reverse stock split.

Northrop Grumman Receives $7M DARPA Contract To Develop Microchips Cooled By Diamond

https://news.northropgrumman.com/microelectronics/northrop-grumman-advances-microchip-tech-diamond-cooling-innovation

AIxCrypto Announces The First Commercial Example Of The RoboShare Business Flywheel, As An Upcoming One-year, $33,000 Long-Term Robot Rental Order Helped Drive The Expansion Of An Education-Sector Customer's Planned Purchase From 5 NAVI Robots To A Signed Order For 23 FFAI Robots; Launches North American RoboShare & Co. Dealer Program

Long-Term Rental Demand Drives Robot Sales, While RoboShare & Co. Enables Dealers to Participate in Post-Delivery Shared Rentals and OperationsLOS ANGELES, Aug. 27, 2026 /PRNewswire/ -- AIxCrypto Holdings, Inc.

Ooma shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 guidance above estimates. Also, the company raised its FY27 guidance above estimates.

UBS Maintains Sell on Everpure, Raises Price Target to $80

UBS analyst David Vogt maintains Everpure (NYSE:P) with a Sell and raises the price target from $70 to $80.

RBC Capital Maintains Outperform on NVIDIA, Raises Price Target to $330

RBC Capital analyst Srini Pajjuir maintains NVIDIA (NASDAQ:NVDA) with a Outperform and raises the price target from $300 to $330.

Inside Supermicro's Stock Gain: How NVIDIA's Record Q2 Drives Data Center Demand

Supermicro stock jumped over 4% premarket following Nvidia's standout Q2 earnings, highlighting continued strong demand for high-performance AI server infrastructure.

Reported Earlier: Celularity And MuseCell Innovations Expand U.S. Manufacturing Collaboration, With Potential For $300M+ In Purchases Over Five Years

Collaboration is intended to expand U.S. manufacturing of Dezawa MuseCells® initially across qualified perinatal sources using the licensed Dezawa Method™ and manufacturing of DMC derived products, including Dezawa

RBC Capital Maintains Outperform on CrowdStrike Holdings, Raises Price Target to $260

RBC Capital analyst Matthew Hedberg maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Outperform and raises the price target from $256 to $260.

Mesoblast shares are trading higher after the company reported better-than-expected FY sales results.

UBS Maintains Buy on Okta, Raises Price Target to $200

UBS analyst Roger Boyd maintains Okta (NASDAQ:OKTA) with a Buy and raises the price target from $150 to $200.

RBC Capital Maintains Outperform on Agilent Technologies, Raises Price Target to $185

RBC Capital analyst Dan Leonard maintains Agilent Technologies (NYSE:A) with a Outperform and raises the price target from $155 to $185.

UBS Maintains Buy on NVIDIA, Raises Price Target to $300

UBS analyst Timothy Arcuri maintains NVIDIA (NASDAQ:NVDA) with a Buy and raises the price target from $280 to $300.

RBC Capital Maintains Sector Perform on FactSet Research Systems, Raises Price Target to $304

RBC Capital analyst Ashish Sabadra maintains FactSet Research Systems (NYSE:FDS) with a Sector Perform and raises the price target from $240 to $304.

UBS Maintains Neutral on HP, Raises Price Target to $28

UBS analyst David Vogt maintains HP (NYSE:HPQ) with a Neutral and raises the price target from $26 to $28.